Find a Clinical Trial | Find out about new
research studies
for neuroblastoma | |
|
|
Each year, 80 or more patients come to Memorial Sloan-Kettering seeking treatment for neuroblastoma -- more than any other hospital in the country. As the number of new patients with neuroblastoma seeking therapy at Memorial Sloan-Kettering steadily increases, physicians here continue to explore and broaden treatment options directed at neuroblastoma. Investigators are also studying the molecular and genetic makeup of neuroblastoma tumors, hoping in the near future to be able to identify why some are more aggressive and, as a result, deserve more intensive treatment. These research programs are partly funded by federal grants, including a five-year Pediatric Program Project Grant awarded by the NCI to Memorial Sloan-Kettering in 2005.
In addition to basic research, our physicians have a close collaboration with our Department of Integrative Medicine, in which we explore and administer supportive therapies in children, including acupuncture, relaxation therapy, music therapy, and complementary medicine. Supported by a five-year Botanical Research Grant awarded to Memorial Sloan-Kettering by the National Cancer Institute and the National Center for Complementary and Alternative Medicine in 2005, doctors on the neuroblastoma team are working with members of the Department of Integrative Medicine to study novel botanicals, which may add another dimension to neuroblastoma treatment.
